Literature DB >> 18333176

Analysis of long-term survivors after surgical resection for invasive pancreatic cancer.

Shigehiro Kure1, Tetsuya Kaneko, Shin Takeda, Soichiro Inoue, Akimasa Nakao.   

Abstract

Pancreatic cancer remains a lethal disease. Although there are many reports on the survival rates of pancreatic cancer patients after surgical resection, the clinicopathological characteristics that influence long-term survival over 5 years remain controversial. Here, we clarify the favourable prognostic factors for long-term survival. One hundred and eighty-two patients with pancreatic cancer underwent surgical resections from 1981 to 1997 in our department. Among them, eight patients survived for at least 5 years after the surgery. The clinicopathological characteristics of the eight long-term survivors who underwent radical resections were studied retrospectively. R0 surgical resections, including five combined with portal vein resections (62.5%), were achieved in these eight patients. Negative invasions of the major regional artery (seven of eight, 87.5%) and to the extrapancreatic nerve plexus (seven of eight, 87.5%), and N0 or Nl lymph node metastasis (7 of 8, 87.5%) were detected as clinicopathological features of long-term survivors in our study. No exposure of carcinoma at the dissected surface and cut end (seven of eight, 87.5%) was characteristically confirmed by pathology. Portal vein invasion was seen in three of the eight patients (37.5%). For long-term survival in cases of pancreatic cancer, complete R0 resections should be performed and negative invasions in the major regional arteries and to the extrapancreatic plexus of the nerve were necessary. No invasion to the portal vein was not necessarily required if R0 was achieved by combined resection of the portal vein.

Entities:  

Year:  2005        PMID: 18333176      PMCID: PMC2023937          DOI: 10.1080/13651820510003744

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  34 in total

1.  Extrapancreatic nerve plexus invasion by carcinoma of the head of the pancreas. Diagnosis with intraportal endovascular ultrasonography.

Authors:  T Kaneko; A Nakao; S Inoue; S Nomoto; T Nagasaka; N Nakashima; A Harada; T Nonami; H Takagi
Journal:  Int J Pancreatol       Date:  1996-02

2.  Isolated pancreatectomy for pancreatic head carcinoma using catheter bypass of the portal vein.

Authors:  A Nakao; H Takagi
Journal:  Hepatogastroenterology       Date:  1993-10

3.  Clinical significance of portal invasion by pancreatic head carcinoma.

Authors:  A Nakao; A Harada; T Nonami; T Kaneko; S Inoue; H Takagi
Journal:  Surgery       Date:  1995-01       Impact factor: 3.982

4.  Lymph node involvement and pancreatic resection: correlation with prognosis and local disease control in a clinical trial.

Authors:  P A Johnstone; W F Sindelar
Journal:  Pancreas       Date:  1993-09       Impact factor: 3.327

5.  Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy.

Authors:  C G Willett; K Lewandrowski; A L Warshaw; J Efird; C C Compton
Journal:  Ann Surg       Date:  1993-02       Impact factor: 12.969

6.  Intraportal endovascular ultrasonography in the diagnosis of portal vein invasion by pancreatobiliary carcinoma.

Authors:  T Kaneko; A Nakao; S Inoue; A Harada; T Nonami; S Itoh; T Endo; H Takagi
Journal:  Ann Surg       Date:  1995-12       Impact factor: 12.969

7.  Prognostic indicators for survival after resection of pancreatic adenocarcinoma.

Authors:  R J Geer; M F Brennan
Journal:  Am J Surg       Date:  1993-01       Impact factor: 2.565

8.  Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy.

Authors:  J G Fortner; D S Klimstra; R T Senie; B J Maclean
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

9.  Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

Authors:  S S Nitecki; M G Sarr; T V Colby; J A van Heerden
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

10.  Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.

Authors:  K C Conlon; D S Klimstra; M F Brennan
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

View more
  10 in total

1.  Extended pancreatic resections and lymphadenectomy: An appraisal of the current evidence.

Authors:  Shailesh V Shrikhande; Savio G Barreto
Journal:  World J Gastrointest Surg       Date:  2010-02-27

2.  Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis.

Authors:  Marco Dal Molin; Ming Zhang; Roeland F de Wilde; Niki A Ottenhof; Neda Rezaee; Christopher L Wolfgang; Amanda Blackford; Bert Vogelstein; Kenneth W Kinzler; Nickolas Papadopoulos; Ralph H Hruban; Anirban Maitra; Laura D Wood
Journal:  Clin Cancer Res       Date:  2015-01-26       Impact factor: 12.531

3.  Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma.

Authors:  Imran Bhatti; Oliver Peacock; Altaf K Awan; David Semeraro; Michael Larvin; Richard I Hall
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

4.  Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray.

Authors:  Mikiko Takikita; Sean Altekruse; Charles F Lynch; Mark T Goodman; Brenda Y Hernandez; Mark Green; Wendy Cozen; Myles Cockburn; Maria Sibug Saber; Marie Topor; Chris Zeruto; Behnoush Abedi-Ardekani; Marsha E Reichman; Stephen M Hewitt
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

5.  Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas.

Authors:  Shih-Chin Chen; Yi-Ming Shyr; Shin-E Wang
Journal:  HPB (Oxford)       Date:  2013-03-08       Impact factor: 3.647

6.  The role of lymph nodes in predicting the prognosis of ampullary carcinoma after curative resection.

Authors:  Shih-Chin Chen; Yi-Ming Shyr; Shu-Cheng Chou; Shin-E Wang
Journal:  World J Surg Oncol       Date:  2015-07-25       Impact factor: 2.754

7.  Effect of surgery on pancreatic tumor-dependent lymphocyte asset: modulation of natural killer cell frequency and cytotoxic function.

Authors:  Francesco Iannone; Alessandra Porzia; Giovanna Peruzzi; Patrizia Birarelli; Bernardina Milana; Luca Sacco; Giuseppe Dinatale; Nadia Peparini; Giampaolo Prezioso; Simone Battella; Roberto Caronna; Stefania Morrone; Gabriella Palmieri; Fabrizio Mainiero; Piero Chirletti
Journal:  Pancreas       Date:  2015-04       Impact factor: 3.327

8.  Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy.

Authors:  Xin Zhao; Li-Xin Li; Hua Fan; Jian-Tao Kou; Xian-Liang Li; Ren Lang; Qiang He
Journal:  J Int Med Res       Date:  2016-11-10       Impact factor: 1.671

9.  Using Attenuated Total Reflection-Fourier Transform Infra-Red (ATR-FTIR) spectroscopy to distinguish between melanoma cells with a different metastatic potential.

Authors:  Refael Minnes; Mati Nissinmann; Yael Maizels; Gabi Gerlitz; Abraham Katzir; Yosef Raichlin
Journal:  Sci Rep       Date:  2017-06-29       Impact factor: 4.379

10.  Surgical management of periampullary adenocarcinoma: defining an optimal prognostic lymph node stratification schema.

Authors:  Chaobin He; Yize Mao; Jun Wang; Xin Huang; Xiaojun Lin; Shengping Li
Journal:  J Cancer       Date:  2018-04-18       Impact factor: 4.207

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.